Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin for urinary obstruction symptoms in adult women
IRCT20221223056903N1Phase 2Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of terazosin in Micturition disorder and bladder outlet obstruction (BOO), sponsored by Sabzevar University of Medical Sciences. Primary endpoints: International Prostate Symptom Score change, Post-void residual urine volume and 1 more. Started Feb 2023; status: completed.
02
Drugs
terazosin
03
Conditions
Micturition disorderbladder outlet obstruction (BOO)
Beyond the preview
Go deeper on IRCT20221223056903N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221223056903N1.